Immunoassay Market Grows USD 12.55 Billion| Predictive and preventive medicine for early diagnosis and treatment to stimulate growth | 17000+ Technavio Reports


NEW YORK, December 17, 2021 /PRNewswire/ — The market for immunoassays is fragmented, and the degree of fragmentation will decrease over the forecast period. Abbott Laboratories, bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., PerkinElmer Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens AG, Tecan Group Ltd. and Thermo Fisher Scientific Inc. are among the main market participants. The market for immunoassays will grow through: USD 12.55 billion from 2021 to 2026. However, growth momentum is likely to slow by a CAGR of 7.40% during the forecast period, according to Technavio.

Attractive Opportunities in Immunoassay Market by Product and Geography – Forecast and Analysis 2022-2026

To know the exact growth variance and YOY growth rateRequest a free sample report.

Immunoassay Market 2022-2026: Scope

Technavio provides a detailed picture of the market through the study, synthesis and summation of data from multiple sources. Our immunoassay market report covers the following areas:

Immunoassay market 2022-2026: drivers and challenges

Predictive and preventive medicine for early diagnosis and treatment, and the advancement in laboratory automation platforms offers enormous growth opportunities. however, the limited number of skilled professionals will challenge the growth of market participants. The holistic analysis of the drivers and challenges will help in deriving end goals and refining marketing strategies to gain a competitive advantage. To take full advantage of the opportunities, market vendors need to focus more on the growth prospects in the high-growth segments, while maintaining their positions in the slow-growing segments.

Immunoassay Market 2022-2026: Segmentation

The market research report provides detailed information about the competitive intelligence, marketing gaps, segmentation and regional opportunities for suppliers, which will help in making efficient business plans.

Immunoassay Market 2022-2026: Key Regions and Revenue Generating Segment

44% of the market’s growth will come from North America during the forecast period. The US is the leading market for immunoassay in North America. However, the market growth in this region will be slower than the market growth in the European and Asian regions. The rapidly growing elderly population and high prevalence of chronic and infectious diseases will facilitate the growth of the immunoassay market in the coming years North America during the forecast period.

The immunoassay market share of growth by the segment reagents and kits will be important for monetization. The Technavio report provides an accurate forecast of the contribution of all segments to the growth of the immunoassay market size and actionable market insights for each segment.

Immunoassay Market 2022-2026: Key Highlights

  • CAGR of the market during the forecast period 2022-2026

  • Detailed information on factors that will support Immunoassay market growth over the next five years

  • – Estimation of the Immunoassay market size and its contribution to the parent market

  • Predictions on emerging trends and changes in consumer behavior

  • The growth of the immunoassay market

  • Analysis of the competitive landscape of the market and detailed information about suppliers

  • Comprehensive details of factors that will challenge the growth of immunoassay market vendors:

Subscribe to our “Lite Plan” billed annually on USD 3000 which allows you to download 3 reports/year and view 3 reports/month.

Related reports:

Cancer Immunotherapy Market –Cancer immunotherapy market share is expected to increase by USD 74.45 billion from 2021 to 2026, and the market growth momentum is set to accelerate at a CAGR of 14.67%. Download a free sample now!

Smoking cessation and nicotine addiction market – The market share of smoking cessation and nicotine addiction is expected to increase by $18.01 billion from 2020 to 2025, and the market growth momentum is set to accelerate at a CAGR of 11.59%. Download a free sample now!

Market size of the immunoassay

Reporting coverage

Details

page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Slow down at a CAGR of 7.40%

Market growth 2022-2026

USD 12.55 billion

Market structure

fragmented

YoY Growth (%)

9.99

Regional analysis

North America, Europe, Asia and ROW

Performing Market Contribution

North America at 44%

Main consumer countries

US, UK, China, Germany and France

Competitive landscape

Leading Companies, Competitive Strategies, Consumer Engagement Range

Profiled companies

Abbott Laboratories, bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., PerkinElmer Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens AG, Tecan Group Ltd. and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Inductors and obstacles to market growth, Analysis of high-growth and slow-growing segments, COVID-19 impact and future consumer dynamics, analysis of market conditions for the forecast period,

Adjustment Range

If our report doesn’t provide the data you’re looking for, contact our analysts and have segments tailored.

About us

Technavio is a leading global technology research and consultancy company. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With more than 500 specialist analysts, Technavio’s report library consists of more than 17,000 reports and 800 technologies across 50 countries. Their customer base consists of companies of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s extensive coverage, extensive research and actionable market insights to identify opportunities in existing and potential markets and assess their competitive position within changing market scenarios.

Contact
Technological research
Jesse Maida
Media & Marketing Executive
USA: +1 844 364 1100
UK: +44 203 893 3200
E-mail: [email protected]
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)

Technavio (PRNewsfoto/Technavio)

decide

decide

View original content to download multimedia: https://www.prnewswire.com/news-releases/immunoassay-market-to-grow-by-usd-12-55-bn-predictive-and-preventive-medicine-for- early-diagnosis-treatment-to-growth-17000-technavio-reports-301447165.html

SOURCE Technavio